The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer announced on Friday. Elinzanetant is now the first and only dual neurokinin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results